Rheonix, a developer of molecular diagnostic platforms, will present data of its automated KRAS CARD molecular diagnostic assay. The KRAS CARD is designed to detect seven known somatic mutations of KRAS oncogene from either fresh or ...
Tags: Rheonix, KRAS CARD, diagnostic assay, KRAS assay